GENENTECH USA, INC.

Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; Issues related to Medicare Part B, CMS coverage and reimbursement; Issues related to healthcare access, quality and costs; S. 2973, The Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, The Lower Costs, More Transparency Act

Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Issues related to 340b drug pricing program

Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; Issues related to Medicare Part B, CMS coverage and reimbursement; S. 2973, The Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, The Lower Costs, More Transparency Act; Issues related to Medicaid Drug Rebate Program

Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Issues related to 340b drug pricing program; Expiring healthcare extenders; S. 1339, The Pharmacy Benefit Manager Reform Act; H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42); H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47); Issues related to 340b

Issues related to biosecurity